Avanos Medical (AVNS) Net Income Growth (1y) (2014 - 2024)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -18.72% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 13.91% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -11.74% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 99.11% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 4,440.69% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 89.28% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -30.10% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Avanos Medical | 1.17 Bn | 1.10 Bn | 94.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 40.00% |
| Sep 30, 2024 | -131.37% |
| Jun 30, 2024 | 96.08% |
| Mar 31, 2024 | -119.18% |
| Dec 31, 2023 | -106.94% |
| Sep 30, 2023 | 8.51% |
| Jun 30, 2023 | -928.57% |
| Mar 31, 2023 | 35.19% |
| Dec 31, 2022 | 128.02% |
| Sep 30, 2022 | 113.31% |
| Jun 30, 2022 | -80.00% |
| Mar 31, 2022 | 164.29% |
| Dec 31, 2021 | 47.55% |
| Sep 30, 2021 | -282.90% |
| Jun 30, 2021 | 1,383.33% |
| Mar 31, 2021 | -327.03% |
| Dec 31, 2018 | -98.24% |
| Jun 30, 2018 | 19.30% |
| Mar 31, 2018 | 13.72% |
| Dec 31, 2017 | 125.11% |
| Sep 30, 2017 | 194.51% |
| Jun 30, 2017 | 338.46% |
| Mar 31, 2017 | 95.07% |
| Dec 31, 2016 | -133.30% |
| Sep 30, 2016 | 101.93% |
| Jun 30, 2016 | -18.75% |
| Mar 31, 2016 | -34.56% |
| Dec 31, 2015 | 14,250.00% |
| Sep 30, 2015 | -6,258.11% |
| Jun 30, 2015 | 277.78% |
| Mar 31, 2015 | -47.58% |
| Dec 31, 2014 | -106.03% |
| Sep 30, 2014 | -115.45% |